Virica has developed a library of Viral Sensitizers (VSE™) that help to reduce these antiviral defenses during production. VSEs alter cellular signaling and dampen antiviral defenses. This unlocks the potential for higher yields, consistent scaleup, and improved critical quality attributes (CQAs) based on application.

VSEs are patented small molecules, including known drugs and novel synthetic compounds, that transiently attenuate antiviral pathways in cells thus enhancing virus production. VSEs are a simple additive introduced at time of infection or transfection and leaves no residual trace after purification.